이재현 (건국대학교)님 | 한빛사연구자 > 한빛사

건국대학교

최종업데이트 2024.08.12.

Reprogramming of cancer metabolism via photoresponsive nano-PROTAC enhances pyroptosis-mediated immunotherapy
- Signal Transduct. Target. Ther., 26 September 2025;10:310 (2025) | https://doi.org/10.1038/s41392-025-02405-6
- 2025-09
- 바이오·의료융합
- 한빛사논문
Tumor-specific biochemical nanoconversion of self-assembled peptide-conjugated paclitaxel-docetaxel-based nanoparticles
- Nano Converg., Apr 26 2025, 12 (1) | https://doi.org/10.1186/s40580-025-00487-0
- 2025-04
- 의약학
- 한빛사논문
Nano-anticoagulant based on carrier-free low molecular weight heparin and octadecylamine with an albumin shuttling effect
- Nat. Commun., 08 August 2024 | https://doi.org/10.1038/s41467-024-50819-7
- 2024-08
- 의약학
- 한빛사논문
Doxorubicin covalently conjugated heparin displays anti-cancer activity as a self-assembled nanoparticle with a low-anticoagulant effect
- Carbohydr. Polym., Available online 18 April 2023 | https://doi.org/10.1016/j.carbpol.2023.120930
- 2023-04
- 바이오·의료융합
- 한빛사논문

연구자 ID

저자논문